Gain Therapeutics, Inc. (GANX) stock
GANXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.11−0.07 (-5.93%)
Close on Nov 18, 2026Market cap $48.44MP/E –Yield –
Gain Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Gain Therapeutics's market cap was $48.11M on Nov 11, 2026, against $125.92M a year earlier. Over the last 5 years it ranged from $19.48M to $125.92M, with a median of $49.47M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $48.11M | -58.5% |
| 2025 | Dec 31, 2025 | $115.84M | +106.6% |
| 2024 | Dec 31, 2024 | $56.08M | +34.4% |
| 2023 | Dec 29, 2023 | $41.74M | +12.2% |
| 2022 | Dec 30, 2022 | $37.19M | -42.3% |
| 2021 | Dec 31, 2021 | $64.51M | – |
See a number that looks wrong?